지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
The purpose of this study was to investigate the effect of naringenin, one of flavonoids, on the pharmacokinetics and bioavailability of diltiazem (15 mg/kg) after oral administration of diltiazem with or without naringenin (2.0, 10 and 20
mg/kg) in rabbits. Coadministration of naringenin increased the absorption rate constant (Ka), the area under the plasma concentration-time curve (AUC) and peak concentration (Cmax) of diltiazem compared to the control group, but only significantly (p<0.05) by 10 mg/kg of naringenin coadministration. The absolute bioavailability (AB%) of diltiazem by coadministration ranges from 7.8% to 10.3%, increased more than control (7.2%), and relative bioavailability (RB%) of diltiazem is increased from 1.08- to 1.43-fold. Coadministration caused on significant changes in the terminal half-lives (t1/2) and the time to reach the peak concentration (Tmax) of diltiazem. On the other hand, coadministration of naringenin increased the AUC desacetyldiltiazem, significantly at the dose of 10mg/kg. But the metabolite ratio (MR) was
decreased, significantly at 10 mg/kg of naringenin. Based on these results, we can make a conclusion that the increased bioavailability and the significant changes of these pharmacokinetic parameters might be due to naringenin, which possess the potency to inhibit the metabolizing enzyme (CYP3A4) in the liver and intestinal mucosa, and also inhibit the
P-glycoprotein efflux pump in the intestinal mucosa.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
흰쥐에서 아톨바스타틴과 딜티아젬의 약물동태학적 상호작용
한국임상약학회지
2007 .01
-
Suppression of CYP1A1 Expression by Naringenin in Murine Hepa-1c1c7 Cells
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2004 .01
-
Naringenin Inhibits Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats
대한약학회 학술대회
2003 .01
-
HT1080 세포주에서 naringenin의 MMP-2, -9 효소 활성 및 발현 억제 효과
Environmental Analysis Health and Toxicology
2009 .03
-
나린게닌의 항균력에 미치는 관련 후라보노이드의 병용효과
약학회지
1992 .01
-
Pharmacokinetics of Diltiazem and Deacetyldiltiazem after Oral Administration of Diltiazem in Mild and Medium Folate-induced Renal Failure Rabbits
대한약학회 학술대회
2000 .01
-
Anti-diabetic and anti-obesity potentials of naringin and naringenin
한국실험동물학회 학술발표대회 논문집
2020 .07
-
Effects of Ticlopidine on the Pharmacokinetics of Diltiazem and Its Main Metabolite, Desacetyldiltiazem, in Rats
Biomolecules & Therapeutics(구 응용약물학회지)
2011 .01
-
Drug Interaction between Diltiazem and Quercetin in Rabbits
대한약학회 학술대회
2003 .01
-
Effect of Atorvastatin on the Pharmacokinetics of Diltiazem and Its Main Metabolite, Desacetyldiltiazem, in Rats
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2007 .01
-
흰쥐에서 플루바스타틴이 딜티아젬 및 그 대사체인 데스아세틸딜티아젬의 약물동태에 미치는 영향
약학회지
2006 .01
-
Pharmacokinetic Changes of Intravenous Diltiazem in Alloxan-Induced Diabetes Mellitus Rabbits
대한약학회 학술대회
2001 .01
-
Down-regulation of naringenin on iNOS, IL-1$\beta$and IL-6, in murine macrophages
대한약학회 학술대회
2001 .01
-
토끼에서 나린진이 틸티아젬과 그대사체, 디아세틸딜티아젬의 생체이용율에 미치는 영향
약학회지
2005 .01
-
Pharmacokinetics of Diltiazem and its Major Metabolite, Deacetyldiltiazem after Oral Administration of Diltiazem in Mild and Medium Folate-Induced Renal Failure Rabbits
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2001 .01
-
Effects of Morin Pretreatment on the Pharmacokinetics of Diltiazem and Its Major Metabolite, Desacetyldiltiazem in Rats
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2005 .01
-
아톨바스타틴과 니페디핀의 약물동태학적 상호작용
한국임상약학회지
2010 .01
-
Effects of citrus aglycone flavonoids, hesperetin and naringenin, on triacylglycerol metabolism in hamsters fed with a cholesterol diet
International journal of oriental medicine : OM
2000 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0